MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Genocea Announces Positive Top-Line Phase 1 Results for Novel Universal Pneumococcus Vaccine Candidate GEN-004.
Brennan CaruthersJune 23, 2014
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Janssen Affiliate Cilag GmbH International Acquires Covagen AG.

Brennan CaruthersAugust 25, 2014
Next

F-star achieves milestone in collaboration with Boehringer Ingelheim.

Brennan CaruthersJanuary 9, 2014

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact